Symbiosis Institute of technology (SIT), Symbiosis International Deemed University (SIDU), Pune- 412115, India.
Symbiosis College of Nursing (SCON), Symbiosis International Deemed University (SIDU), Pune- 412115, India.
Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3429-3437. doi: 10.31557/APJCP.2024.25.10.3429.
The objective of this study is to evaluate the quality of mobile health (mHealth) applications that promote cervical cancer awareness and provide screening assistance, with an emphasis on apps available on the Google Play Store and iOS.
From December 2023 to February 2024, we assessed mobile applications focused on cervical cancer screening that are available on Google Play and Apple iTunes. The "Cervical Cancer," "Mobile Application," "Pap Test," "Cervical Cancer Guide," "Human Papillomavirus," plus "Cervical Screening are the keywords used to search the applications." Data collection includes features such as application name, pricing, download metrics, invention date, last update, affiliation, online access, login requirements, and notification functionality, which were gathered in Excel. Interrater reliability based on four reviewers' independent judgments, varied from 0.75 to 0.83.
In our research, we found 25 apps (16 on the Google Play Store and 9 on iOS). After a thorough review, only 14 relevant apps were included. According to the MARS rating, Rise Against Cancer received the highest score (3.9), followed by FightHPV and Cervical Cancer Forum (3.8). Rise Against Cancer (29), HPV Vaccine (28), and CDC STI Tx Guidelines (28) scored highest in the APPLICATIONS rating system. Hope 4 All and OCI Cervibreast closely matched the statements, meeting seven of the thirteen requirements each.
Future app developers should produce user-friendly, often updated mHealth applications that include high-quality cervical cancer awareness and screening content. These apps should provide validated information and pleasant graphic effects.
本研究旨在评估促进宫颈癌认知和提供筛查辅助的移动健康（mHealth）应用程序的质量，重点关注可在 Google Play 商店和 iOS 上使用的应用程序。
在 2023 年 12 月至 2024 年 2 月期间，我们评估了可在 Google Play 和 Apple iTunes 上使用的专注于宫颈癌筛查的移动应用程序。使用的搜索关键词包括“宫颈癌”、“移动应用程序”、“巴氏涂片检查”、“宫颈癌指南”、“人乳头瘤病毒”和“宫颈癌筛查”。数据收集包括应用程序名称、定价、下载指标、发明日期、最近更新、所属机构、在线访问、登录要求和通知功能等，这些数据均在 Excel 中进行收集。四位评审员的独立判断得出的组内一致性系数为 0.75 至 0.83。
在我们的研究中，共发现 25 个应用程序（Google Play 商店上有 16 个，iOS 上有 9 个）。经过仔细审查，仅纳入了 14 个相关应用程序。根据 MARS 评分，Rise Against Cancer 获得了最高分（3.9），其次是 FightHPV 和 Cervical Cancer Forum（3.8）。在应用程序评分系统中，Rise Against Cancer（29 分）、HPV Vaccine（28 分）和 CDC STI Tx Guidelines（28 分）得分最高。Hope 4 All 和 OCI Cervibreast 与声明非常匹配，每项要求均满足了 7 项。
未来的应用程序开发者应该制作出用户友好、经常更新的 mHealth 应用程序，其中包含高质量的宫颈癌认知和筛查内容。这些应用程序应提供经过验证的信息和令人愉悦的图形效果。
